Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during

Daren R Ure1, Thomas E Lane, Michael T Liu

  • 1Department of Neurology, Mayo Foundation and Graduate School, 428 Guggenheim Building, 201 1st Street SW, Rochester, MN 55905, USA.

Insights

Blocking chemokines like RANTES and MIG during viral infections may worsen disease. This study shows these chemokines help control viral spread and limit immune-mediated damage in the central nervous system.

Area of Science:

  • Neuroimmunology
  • Virology
  • Immunology

Background:

  • Chemokines play a complex role in viral infections, potentially causing both immunity and tissue damage.
  • Theiler's virus infection in SJL mice serves as a model for studying viral-induced central nervous system disease.

Purpose of the Study:

  • To investigate the roles of regulated on activation, normal T cell-expressed and secreted (RANTES) and monokine induced by IFN-gamma (MIG) chemokines in Theiler's virus infection.
  • To determine the impact of blocking these chemokines on viral persistence and immunopathology.

Main Methods:

  • SJL mice were infected with Theiler's virus.
  • Mice were treated with antisera against RANTES and MIG to block chemokine function.
  • Viral antigen expression, inflammation, demyelination, and cytokine profiles (IL-2, IL-10) were assessed.

Main Results:

  • Blocking RANTES or MIG increased viral antigen expression and demyelination severity.
  • Viral load correlated with the extent of spinal cord pathology.
  • RANTES antiserum treatment altered the IL-2/IL-10 ratio, indicating a shift in immune response.

Conclusions:

  • RANTES and MIG are crucial for an immune response that controls viral replication and mitigates immunopathology.
  • Blocking these chemokines can exacerbate viral infection and central nervous system damage.
  • Targeting chemokines in viral infections requires careful consideration of potential long-term adverse effects.

Related Concept Videos